Introduction

Cancer Genomics 2017 is the third EACR conference on this topic, and it has now established itself as the premier European conference dedicated to cancer genomics. In 2017 it will update you on the latest exciting developments: cancers as communities of clones and communities of cells, liquid biopsies, genomics and cancer immunology, mutational processes, and genomic and immune system landscapes of human cancers.

Featuring an exceptional international faculty, extensive networking opportunities and a maximum of 200 participants, this conference will provide an intimate setting for top quality scientific interaction. We look forward to welcoming you to Cambridge for this exciting meeting!

Target audience

Cancer Genomics 2017 will be relevant to participants from across a number of fields including cancer medicine, cancer biology, translational research, bioinformatics, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.

Topics to be covered

• Immunology in the age of single cell genomics
• Towards deciphering the functional genetic and neo antigenic landscape in cancer
• T cell recognition of human cancer
• Exploiting acquired vulnerabilities of drug resistant tumours
• Precision medicine
• Clonal and cellular heterogeneity landscapes of cancer
• Role of rare mutations in the onset of cancer
• Tumour genomes shed light into mutational processes and cancer vulnerabilities
• Molecular analysis of circulating tumour cells
• Inferring expressed genes by whole-genome sequencing of plasma DNA
• Predicting relapse using circulating tumour DNA
• Patient-derived primary cancer cells, integrative omics and functional drug testing
• Tracking cancer evolution

Scientific Programme Committee: James Brenton (UK), Carlos Caldas (UK), Levi Garraway (USA) and Yardena Samuels (Israel)

Venue

Churchill College, a unique collegiate atmosphere just outside of the city centre.